TIDM3DD

RNS Number : 3931Q

3D Diagnostic Imaging PLC

18 October 2011

 
 For immediate release   18 October 2011

3D DIAGNOSTIC IMAGING PLC

("3D" or the "Company")

Result of Extraordinary General Meeting

3D Diagnostic Imaging (AIM:3DD), which owns the protected rights to a technology platform with a number of significant potential commercial applications, is pleased to announce that all resolutions proposed at its extraordinary general meeting held earlier today were duly passed, and consequently, that the equity fundraising of GBP1.41m as announced on 22 September 2011 has been completed, subject to admission to trading of the Placing and Subscription Shares.

Following the approval by shareholders of the resolution allowing the transfer of management and control of the Company from the Isle of Man to the United Kingdom, Christina Rawlinson and Pritesh Desai have today stepped down from the Board of Directors. The Board would like to thank them for their past contributions to the Company.

Application has been made for the admission to trading on AIM of the 13,350,000 First Placing Shares, expected to occur on 19 October 2011, and of the total 57,150,000 Second Placing Shares and Subscription Shares, expected to occur on 20 October 2011. Terms defined in the announcement in respect of the fundraising by the Company dated 22 September 2011 have the same meaning in this announcement unless otherwise stated.

Subsequent to the issue of the aggregate 70,500,000 New Ordinary Shares (being, together, the First Placing Shares, the Second Placing Shares and the Subscription Shares), the Company will have 240,974,824 ordinary shares of 0.1p each in issue, with each share carrying the right to one vote. There are no shares held in treasury. The total number of voting rights in the Company will therefore be 240,974,824.

The above figure may be used by shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change to their interest in, the Company under the Disclosure and Transparency Rules.

Ends

ENDS

For further information please contact:

 
  3D Diagnostic Imaging 
   Plc 
   Graham Lay, CEO            +44 (0) 1624 679 000 
   Oliver Cooke, CFO          +44 (0) 1624 679 000 
 
   finnCap: NOMAD & Broker 
   Geoff Nash, Henrik 
    Persson (corporate 
    finance) Stephen 
    Norcross (corporate 
    broking)                  +44 (0) 2076 001 658 
 
   Buchanan Scotland 
   Diane Stewart, Carrie 
    Clement                   +44 (0) 131 226 6150

This information is provided by RNS

The company news service from the London Stock Exchange

END

REGEADEPFEPFFFF

3D Diagnostic (LSE:3DD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more 3D Diagnostic Charts.
3D Diagnostic (LSE:3DD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more 3D Diagnostic Charts.